Gene Regulation Network of Prognostic Biomarker YAP1 in Human Cancers: An Integrated Bioinformatics Study
| Autor: | Honglin Ke, Ronghu Ke, Zhaoping Zhou, Shao Tang, Xinjie Tang, Baojin Wu, Qiong Zhou |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
0301 basic medicine
Cancer Research Mitochondrial DNA YAP1 Biology medicine.disease_cause Pathology and Forensic Medicine 03 medical and health sciences 0302 clinical medicine Neoplasms Biomarkers Tumor medicine Humans cancer Gene Regulatory Networks Mitochondrial respiratory chain complex I Gene Original Research Regulation of gene expression Hippo signaling pathway bioinformatic Gene Expression Profiling Computational Biology YAP-Signaling Proteins Pathology and Oncology Archive General Medicine Prognosis mitochondrial Survival Rate 030104 developmental biology Oncology 030220 oncology & carcinogenesis Cancer research Biomarker (medicine) Carcinogenesis |
| Zdroj: | Pathology and Oncology Research |
| ISSN: | 1532-2807 |
| DOI: | 10.3389/pore.2021.1609768 |
| Popis: | Background: Yes-associated protein 1 (YAP1) is the main downstream effector of the Hippo signaling pathway, which is involved in tumorigenesis. This study aimed to comprehensively understand the prognostic performances of YAP1 expression and its potential mechanism in pan-cancers by mining databases.Methods: The YAP1 expression was evaluated by the Oncomine database and GEPIA tool. The clinical significance of YAP1 expression was analyzed by the UALCAN, GEPIA, and DriverDBv3 database. Then, the co-expressed genes with YAP1 were screened by the LinkedOmics, and annotated by the Metascape and DAVID database. Additionally, by the MitoMiner 4.0 v tool, the YAP1 co-expressed genes were screened to obtain the YAP1-associated mitochondrial genes that were further enriched by DAVID and analyzed by MCODE for the hub genes.Results: YAP1 was differentially expressed in human cancers. Higher YAP1 expression was significantly associated with poorer overall survival and disease-free survival in adrenocortical carcinoma (ACC), brain Lower Grade Glioma (LGG), and pancreatic adenocarcinoma (PAAD). The LinkedOmics analysis revealed 923 co-expressed genes with YAP1 in adrenocortical carcinoma, LGG and PAAD. The 923 genes mainly participated in mitochondrial functions including mitochondrial gene expression and mitochondrial respiratory chain complex I assembly. Of the 923 genes, 112 mitochondrial genes were identified by MitoMiner 4.0 v and significantly enriched in oxidative phosphorylation. The MCODE analysis identified three hub genes including CHCHD1, IDH3G and NDUFAF5.Conclusion: Our findings showed that the YAP1 overexpression could be a biomarker for poor prognosis in ACC, LGG and PAAD. Specifically, the YAP1 co-expression genes were mainly involved in the regulation of mitochondrial function especially in oxidative phosphorylation. Thus, our findings provided evidence of the carcinogenesis of YAP1 in human cancers and new insights into the mechanisms underlying the role of YAP1 in mitochondrial dysregulation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|